check_circleStudy Completed

Contraception, Contraceptive Devices, Intrauterine

Study to evaluate efficacy, safety, and pharmacokinetics of Levonorgestrel-releasing intrauterine system SH G 00650 A

Trial purpose

Please see attached Study Results Summary below.

Key Participants Requirements

Sex

N/A

Age

N/A

Trial summary

Enrollment Goal
482
Trial Dates
April 2001 - June 2003
Phase
Phase 3
Could I Receive a placebo
N/A
Products
Mirena (Levonorgestrel IUS, BAY86-5028)
Accepts Healthy Volunteer
N/A

Primary Outcome

Secondary Outcome

Trial design

A Multicenter, Open-Label, Non-Randomized Study of SH G 00650 A (Levonorgestrel Intrauterine System) in Parous Women Seeking Contraception to Evaluate its Efficacy, Safety, and Pharmacokinetic Profile When Inserted for 12 months
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A